Effect of PI3K- and mTOR-specific inhibitors on spontaneous B-cell follicular lymphomas in PTEN/LKB1-deficient mice

BACKGROUND: The PI3K–mTOR (phosphoinositide 3-kinase–mammalian target of rapamycin kinase) pathway is activated in the majority of tumours, and there is interest in assessing whether inhibitors of PI3K or mTOR kinase have efficacy in treating cancer. Here, we define the effectiveness of specific mTO...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Martínez, J M, Wullschleger, S, Preston, G, Guichard, S, Fleming, S, Alessi, D R, Duce, S L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068512/
https://www.ncbi.nlm.nih.gov/pubmed/21407213
http://dx.doi.org/10.1038/bjc.2011.83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068512/
https://www.ncbi.nlm.nih.gov/pubmed/21407213
http://dx.doi.org/10.1038/bjc.2011.83

Ejemplares similares